As of Oct 12, 2026 close
- Market cap
- $1.09B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $27.00$54.85
- Volume (live)
- -
- Avg. volume (3M)
- 586.05K
Harrow (HROW) Stock Price & Financial Analysis
Harrow Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $28.86 - $29.73 |
|---|---|
| 52-Week High | $54.85 |
| 52-Week Low | $27.00 |
| Open | $29.38 |
| Volume (last close) | 577.02K |
| Average Volume (3M) | 586.05K |
| Market Cap | 1.09B |
|---|---|
| Shares Outstanding | 37.35M |
| Price to Sales (P/S) | 3.95 |
| Price to Book (P/B) | 71.53 |
| EV/EBITDA | 125.55 |
| Revenue (TTM) | 275.59M |
|---|---|
| Net Income (TTM) | -37.23M |
| Free Cash Flow (TTM) | 5.00M |
| EPS (TTM) | $-0.98 |
| Profit Margin | -13.51% |
| Operating Margin | -1.00% |
| Return on Equity (ROE) | -244.91% |
| Debt to Equity | 19.30 |
| 50-Day MA | $36.10 |
|---|---|
| 200-Day MA | $39.86 |
| 1-Year Change | −24.92% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Harrow at a Glance
Harrow (HROW) has a market capitalization of $1.09B. The stock trades at 4.0× sales. Over the trailing twelve months it lost $37.23M on revenue of $275.59M and generated $5.00M of free cash flow. Revenue grew 21.1% year over year.
It holds $83.89M in cash and securities against $293.32M of debt, a net debt position of $209.43M.
Harrow does not currently pay a dividend.
The share price is down 24.9% over the past year. At $29.11 it sits near the bottom of its 52-week range of $27.00 to $54.85, below its 200-day moving average of $39.86.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $64.33, 121.0% above the latest close.
Frequently Asked Questions About Harrow
What is the current stock price for HROW?
As of the Oct 12, 2026 close, HROW stock trades at $29.11. The 52-week range is $27.00–$54.85, with a day range of $28.86–$29.73.
What is the P/E ratio for HROW?
The P/E ratio (Price-to-Earnings) for HROW is shown in the Key Statistics section. This valuation metric helps compare Harrow, Inc. to industry peers.
Does HROW pay dividends?
Harrow does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for HROW?
Based on 8 analysts, the consensus for HROW is Buy.
What is the market cap of HROW?
Harrow's market capitalization is $1.09B, classifying it as a small-cap company. Harrow operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.